# | Title | Journal | Year | Citations |
---|
1 | New Guidelines to Evaluate the Response to Treatment in Solid Tumors | Journal of the National Cancer Institute | 2000 | 14,815 |
2 | The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology | Journal of the National Cancer Institute | 1993 | 12,309 |
3 | Statistical aspects of the analysis of data from retrospective studies of disease | Journal of the National Cancer Institute | 1959 | 9,499 |
4 | New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening | Journal of the National Cancer Institute | 1990 | 8,381 |
5 | Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study | Journal of the National Cancer Institute | 1998 | 5,238 |
6 | Photodynamic Therapy | Journal of the National Cancer Institute | 1998 | 4,721 |
7 | Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease | Journal of the National Cancer Institute | 0 | 4,659 |
8 | What Is the Evidence That Tumors Are Angiogenesis Dependent? | Journal of the National Cancer Institute | 1990 | 4,220 |
9 | The Causes of Cancer: Quantitative Estimates of Avoidable Risks of Cancer in the United States Today | Journal of the National Cancer Institute | 1981 | 3,390 |
10 | Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective | Journal of the National Cancer Institute | 1995 | 3,021 |
11 | Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually | Journal of the National Cancer Institute | 1989 | 2,934 |
12 | Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines | Journal of the National Cancer Institute | 1991 | 2,856 |
13 | Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers | Journal of the National Cancer Institute | 2000 | 2,586 |
14 | Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects | Journal of the National Cancer Institute | 2001 | 2,581 |
15 | Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial | Journal of the National Cancer Institute | 2008 | 2,397 |
16 | Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis | Journal of the National Cancer Institute | 2014 | 2,202 |
17 | Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers | Journal of the National Cancer Institute | 2005 | 2,194 |
18 | Projections of the Cost of Cancer Care in the United States: 2010-2020 | Journal of the National Cancer Institute | 2011 | 2,151 |
19 | A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2 | Journal of the National Cancer Institute | 1973 | 2,082 |
20 | In Vitro Cultivation of Human Tumors: Establishment of Cell Lines Derived From a Series of Solid Tumors2 | Journal of the National Cancer Institute | 1973 | 1,999 |
21 | Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer | Journal of the National Cancer Institute | 2009 | 1,844 |
22 | Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis | Journal of the National Cancer Institute | 2006 | 1,824 |
23 | Drug Resistance and the Solid Tumor Microenvironment | Journal of the National Cancer Institute | 2007 | 1,795 |
24 | Specific Genetic Predictors of Chemotherapeutic Response and Survival in Patients With Anaplastic Oligodendrogliomas | Journal of the National Cancer Institute | 1998 | 1,759 |
25 | Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast Carcinoma | Journal of the National Cancer Institute | 1992 | 1,688 |
26 | Tobacco Smoke Carcinogens and Lung Cancer | Journal of the National Cancer Institute | 1999 | 1,674 |
27 | Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy | Journal of the National Cancer Institute | 2008 | 1,632 |
28 | Nutrition Intervention Trials in Linxian, China: Supplementation With Specific Vitamin/Mineral Combinations, Cancer Incidence, and Disease-Specific Mortality in the General Population | Journal of the National Cancer Institute | 1993 | 1,620 |
29 | A Family of Drug Transporters: the Multidrug Resistance-Associated Proteins | Journal of the National Cancer Institute | 2000 | 1,579 |
30 | A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma | Journal of the National Cancer Institute | 2002 | 1,557 |
31 | Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies | Journal of the National Cancer Institute | 2004 | 1,553 |
32 | Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma | Journal of the National Cancer Institute | 2008 | 1,545 |
33 | Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer | Journal of the National Cancer Institute | 2005 | 1,517 |
34 | Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies | Journal of the National Cancer Institute | 2002 | 1,510 |
35 | Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group | Journal of the National Cancer Institute | 2011 | 1,505 |
36 | Cancer Risks in BRCA2 Mutation Carriers | Journal of the National Cancer Institute | 1999 | 1,445 |
37 | Changing views of the role of matrix metalloproteinases in metastasis | Journal of the National Cancer Institute | 1997 | 1,438 |
38 | Phases of Biomarker Development for Early Detection of Cancer | Journal of the National Cancer Institute | 2001 | 1,431 |
39 | Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial | Journal of the National Cancer Institute | 2006 | 1,422 |
40 | One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23 | Journal of the National Cancer Institute | 1977 | 1,416 |
41 | Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition Staging | Journal of the National Cancer Institute | 2004 | 1,411 |
42 | Overdiagnosis in Cancer | Journal of the National Cancer Institute | 2010 | 1,392 |
43 | Model Predicting Survival in Stage I Melanoma Based on Tumor Progression | Journal of the National Cancer Institute | 1989 | 1,341 |
44 | Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers | Journal of the National Cancer Institute | 2008 | 1,339 |
45 | Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) | Journal of the National Cancer Institute | 2005 | 1,323 |
46 | Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial | Journal of the National Cancer Institute | 2008 | 1,316 |
47 | Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical Issues | Journal of the National Cancer Institute | 2002 | 1,300 |
48 | Tomatoes, Tomato-Based Products, Lycopene, and Cancer: Review of the Epidemiologic Literature | Journal of the National Cancer Institute | 1999 | 1,266 |
49 | Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial | Journal of the National Cancer Institute | 1996 | 1,242 |
50 | Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 * | Journal of the National Cancer Institute | 1994 | 1,233 |